StudyFinder
The Fourth Left Atrial Appendage Occlusion Study: (LAAOS-4)
Status: Recruiting
The purpose of the LAAOS-4 study is to determine if closure of the left atrial appendage using a closure device called the WATCHMAN?, in addition to taking oral anticoagulant medications, is more effective at reducing strokes and blood clots in your body, than taking oral anticoagulant medications on their own.
Sex: Male or Female
Age: 18 years and over
Healthy Volunteers:
Inclusion Criteria:
• Adults, 18 years or older
• Have long-term atrial fibrillation (persistent or permanent) OR paroxysmal atrial fibrillation with a history of stroke or blood clots
• Taking an oral anticoagulant
Exclusion Criteria:
• Unable to tolerate oral anticoagulants
• Prior closure of the left atrial appendage
Interventions:
Drug/Device: WATCHMAN device
Conditions:
Atrial Fibrillation
Keywords:
Atrial Fibrillation, oral anticoagulation, WATCHMAN
Contact(s): Briita Wanhala - bwanhal1@hfhs.org
Principal Investigator: Waddah Maskoun
Principal Investigator ID: wmaskou1@hfhs.org
Phase: N/A
See this study on ClinicalTrials.gov